Cargando…
Febuxostat Therapy for Patients with Gout and Stage 2–4 CKD: a Retrospective Study
INTRODUCTION: The aim of this study is to explore the efficacy and renal safety of febuxostat in gout and stage 2–4 chronic kidney disease (CKD) and factors that correlated with target serum urate (SU). METHODS: A single-center retrospective study including male patients with gout and CKD was conduc...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510076/ https://www.ncbi.nlm.nih.gov/pubmed/36057763 http://dx.doi.org/10.1007/s40744-022-00480-7 |